<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04291235</url>
  </required_header>
  <id_info>
    <org_study_id>NEURO-ETT</org_study_id>
    <nct_id>NCT04291235</nct_id>
  </id_info>
  <brief_title>The NEUROlogically-impaired Extubation Timing Trial (NEURO-ETT)</brief_title>
  <official_title>The NEUROlogically-impaired Extubation Timing Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial in brain-injured patients will test which of the following will lead to better
      patient outcomes: (1) an airway management pathway consisting of daily assessments and
      removal of the breathing tube as soon as patients can breathe on their own and appear able to
      protect their airway; versus (2) the usual treatment patients would have received if they
      were not enrolled in this trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thousands of patients suffer severe brain injuries every year, from causes such as trauma,
      stroke, and infection. These patients are usually not fully awake and need help with their
      breathing and with preventing them from choking on their secretions. This is done with a
      breathing tube inserted through the mouth into the lungs and connected to a breathing
      machine. As patients recover, It is often unclear when the best time is to remove the
      breathing tube. Doctors might decide to remove it relatively early, or they may wait until
      the patient is more fully awake, or they may perform a tracheostomy (neck surgery to insert a
      new tube directly into the windpipe (trachea), replacing the temporary breathing tube). Each
      of these approaches has risks and benefits. This trial in brain-injured patients will test
      which of the following will lead to better patient outcomes: (1) an airway management pathway
      consisting of daily assessments and removal of the breathing tube as soon as patients can
      breathe on their own and appear able to protect their airway; versus (2) the usual treatment
      patients would have received if they were not enrolled in this trial.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Duration of Mechanical Ventilation</measure>
    <time_frame>Up to 60 Days</time_frame>
    <description>Total duration of mechanical ventilation (to 60 days) accounting for the competing risk of death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at ICU discharge and Hospital Discharge</measure>
    <time_frame>ICU Discharge, Hospital Discharge, 3 months, and 6 months</time_frame>
    <description>Mortality at ICU Discharge, Hospital Discharge, 3 months, and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-Free Days at Day 60</measure>
    <time_frame>Up to 60 days</time_frame>
    <description>Days alive and not receiving mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Free Days At Day 60</measure>
    <time_frame>Up to 60 Days</time_frame>
    <description>ICU free days (days alive and not spent in an ICU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway or Tracheostomy complications</measure>
    <time_frame>Up to 30 days</time_frame>
    <description>Presence versus absence of airway complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutrition Intake</measure>
    <time_frame>Up to 6 Months</time_frame>
    <description>Time to normal oral nutrition intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotics Days</measure>
    <time_frame>Up to 30 Days</time_frame>
    <description>Injection or infusion of antibiotics given intravenously</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheostomy Rates</measure>
    <time_frame>Up to 6 Months</time_frame>
    <description>Presence versus absence of tracheostomy insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Readmission Rates</measure>
    <time_frame>Hospital discharge, up to 90 days</time_frame>
    <description>ICU readmission rates to hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge Destination</measure>
    <time_frame>Hospital discharge, up to 90 days</time_frame>
    <description>Discharge destination for the patient post hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extended Glasgow Outcome Score</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Minimum score 1 (worst) to maximum score 8 (best) at 3 months and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol-5D</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Minimum score 1 (worst) to maximum score 100 (best) at 3 months and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium Free Days</measure>
    <time_frame>Up to 30 Days</time_frame>
    <description>Days alive and free of delirium while in ICU up to day 30</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">332</enrollment>
  <condition>Acute Brain Injury</condition>
  <arm_group>
    <arm_group_label>Airway Management Pathway</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An airway management pathway consisting of daily assessments and removal of the breathing tube as soon as patients can breathe on their own and appear able to protect their airway</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The usual clinical practice is often to keep the patient on artificial respiration for longer in the hope that the patient will wake up before removing the tube, or performing a tracheostomy if the patient doesn't wake up</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Airway Management Pathway</intervention_name>
    <description>Patients in this group will receive several components that comprise airway management pathway: (1) daily spontaneous breathing trials (SBTs); (2) prompt extubation following successful extubation readiness criteria; (3) high-flow nasal oxygen for at least 24 hours following extubation.</description>
    <arm_group_label>Airway Management Pathway</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Patients in this group will be treated according to usual care, which may include extubation or tracheostomy timed according to treating physicians' discretion.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 16 years

          2. Acute brain injury (subarachnoid hemorrhage, diffuse axonal injury, ischemic stroke,
             intracerebral hemorrhage, brain tumor, global cerebral anoxia/cardiac arrest,
             meningitis/encephalitis, cerebral abscess, epidural hematoma, subdural hematoma,
             seizure) that occurred within the previous 4 weeks

          3. Receiving mechanical ventilation via endotracheal tube for ≥ 48 hours

        Exclusion Criteria:

          1. Quadriplegic

          2. Neuromuscular disease that will result in prolong need for mechanical ventilation,
             including but not limited to Guillain-Barre syndrome, cervical spinal cord injury,
             advanced multiple sclerosis

          3. Do-Not-Reintubate order in place

          4. Previously randomized in this trial

          5. Underlying pre-existing condition with life expectancy less than 6-months

          6. Current enrolment in an RCT that precludes NEURO-ETT co-enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niall Ferguson, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Toronto General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Damon Scales, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Venika Manoharan, HBSc</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>88136</phone_ext>
    <email>venika.manoharan@sunnybrook.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>David Zygun, MD</last_name>
      <phone>780-492-8597</phone>
      <email>zygun@ualberta.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Columbian Hospital</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <zip>V3L 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Steven Reynolds, MD</last_name>
      <email>steven.reynolds@fraserhealth.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Donald Griesdale, MD</last_name>
      <phone>604-875-4304</phone>
      <email>Donald.Griesdale@vch.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nova Scotia Health Authority</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Laurel Murphey, MD</last_name>
      <phone>902-473-3486</phone>
      <email>laurel.murphy@nshealth.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Sunjay Sharma, MD</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>44721</phone_ext>
      <email>sharmasun@hhsc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>J. Gordon Boyd, MD</last_name>
      <phone>613-549-6666</phone>
      <phone_ext>6228</phone_ext>
      <email>2jgb1@queensu.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Karen Bosma, MD</last_name>
      <phone>519-663-3531</phone>
      <email>Karenj.Bosma@lhsc.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Shane English, MD</last_name>
      <phone>613-737-8726</phone>
      <email>senglish@ohri.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Damon Scales, MD</last_name>
      <phone>416-480-6100</phone>
      <phone_ext>5291</phone_ext>
      <email>damon.scales@sunnybrook.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrew Baker, MD</last_name>
      <phone>416-864-5559</phone>
      <email>bakera@smh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Jeff Singh, MD</last_name>
      <phone>416-603-5800</phone>
      <phone_ext>3221</phone_ext>
      <email>Jeff.Singh@uhn.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital du Sacré-Coeur de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Emmanuel Charbonney, MD</last_name>
      <phone>514 338 2050</phone>
      <email>emmanuel.charbonney@umontreal.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de l'Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2X 2H8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Michaël Chassé, MD</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>30816</phone_ext>
      <email>michael.chasse.chum@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>L'Hôpital de l'Enfant-Jésus</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1J 1Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexis Turgeon, MD</last_name>
      <phone>418-649-0252</phone>
      <phone_ext>66064</phone_ext>
      <email>alexis.turgeon@fmed.ulaval.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2020</study_first_posted>
  <last_update_submitted>February 27, 2020</last_update_submitted>
  <last_update_submitted_qc>February 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Damon Scales</investigator_full_name>
    <investigator_title>Chief of Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Subarachnoid Hemorrhage</keyword>
  <keyword>Diffuse Axonal Injury</keyword>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Intracerebral Hemorrhage</keyword>
  <keyword>Brain Tumor</keyword>
  <keyword>Global Cerebral Anoxia/Cardiac Arrest</keyword>
  <keyword>Meningitis/Encephalitis</keyword>
  <keyword>Cerebral Abscess</keyword>
  <keyword>Epidural Hematoma</keyword>
  <keyword>Subdural Hematoma</keyword>
  <keyword>Seizure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

